ACT - AdvisorShares Vice ETF

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
26.13
+0.22 (+0.85%)
At close: 3:50PM EDT
Stock chart is not supported by your current browser
Previous Close25.91
Open25.89
Bid0.00 x 900
Ask0.00 x 1000
Day's Range25.89 - 26.44
52 Week Range24.23 - 29.50
Volume9,240
Avg. Volume8,575
Net Assets14.84M
NAV26.98
PE Ratio (TTM)N/A
YieldN/A
YTD Return3.05%
Beta (3Y Monthly)0.00
Expense Ratio (net)0.00%
Inception Date2017-12-11
Trade prices are not sourced from all markets
  • 4/20: Marijuana, hemp legalization moves ahead in many states
    Yahoo Finance Video6 months ago

    4/20: Marijuana, hemp legalization moves ahead in many states

    Senate Democratic leader Chuck Schumer says he’s introducing a bill to decriminalize marijuana at the federal level. Yahoo Finance’s Alexis Christoforous and Dan Ahrens, Managing Director & COO at AdvisorShares, discuss marijuana and hemp sales.

  • InvestorPlace4 days ago

    Fans of Tilray Stock Ought to Ride MJ to Success

    It seems that anyone who invests in marijuana stocks these days has a fundamental reason why they’re backing a particular horse in what’s become the world’s biggest stakes race.10 S&P 500 Stocks to Buy for the Long Term

  • The Zacks Analyst Blog Highlights: United States Gasoline, Invesco Dynamic Building & Construction, Materials Select Sector SPDR Fund and AdvisorShares VICE
    Zacks28 days ago

    The Zacks Analyst Blog Highlights: United States Gasoline, Invesco Dynamic Building & Construction, Materials Select Sector SPDR Fund and AdvisorShares VICE

    The Zacks Analyst Blog Highlights: United States Gasoline, Invesco Dynamic Building & Construction, Materials Select Sector SPDR Fund and AdvisorShares VICE

  • 4 ETFs Set to Soar in the Aftermath of Hurricane Florence
    Zackslast month

    4 ETFs Set to Soar in the Aftermath of Hurricane Florence

    While most of the sectors took a beating from the hurricane, industries like building supplies, home improvement, car rentals and gasoline benefit in the aftermath of hurricane.

  • Why Bausch Health Companies Inc. Stock Is Booming Today
    Motley Foollast month

    Why Bausch Health Companies Inc. Stock Is Booming Today

    Settlement of patent litigation provides a spark for Bausch Health.

  • 5 Vice ETFs That Are Worth Sinning For
    InvestorPlace2 months ago

    5 Vice ETFs That Are Worth Sinning For

    For some investors, there are times when sin is in. While there are an increasing number of exchange-traded funds (ETFs) dedicated to environmental, social and governance (ESG) principles, also known as virtuous investing, there are a smaller number of vice ETFs.

  • If I Had to Buy 1 Stock in August, It Would Be This One
    Motley Fool2 months ago

    If I Had to Buy 1 Stock in August, It Would Be This One

    This healthcare company appears poised to turn a corner.

  • Allergan sues Pfizer over costs of opioid litigation
    Reuters2 months ago

    Allergan sues Pfizer over costs of opioid litigation

    In a lawsuit filed in federal court in Cleveland, Ohio, Allergan said the "primary basis" for the claims against it was the alleged improper marketing and sale of Kadian, a form of morphine, in the years before it gained rights to the painkiller in late 2008. "But now that more than a thousand lawsuits seek to impose liability for that very marketing and sale, Pfizer has rejected any responsibility to indemnify Allergan," alleged Allergan Finance LLC, the subsidiary that filed the lawsuit.

  • Allergan sues Pfizer over costs of opioid litigation
    Reuters2 months ago

    Allergan sues Pfizer over costs of opioid litigation

    In a lawsuit filed in federal court in Cleveland, Ohio, Allergan said the "primary basis" for the claims against it was the alleged improper marketing and sale of Kadian, a form of morphine, in the years before it gained rights to the painkiller in late 2008. "But now that more than a thousand lawsuits seek to impose liability for that very marketing and sale, Pfizer has rejected any responsibility to indemnify Allergan," alleged Allergan Finance LLC, the subsidiary that filed the lawsuit.

  • Allergan Sues Pfizer Over Damages in Opioid Litigation
    Bloomberg2 months ago

    Allergan Sues Pfizer Over Damages in Opioid Litigation

    Allergan Plc sued Pfizer Inc. to cover any potential damages that the drugmaker might be forced to pay as a result of the hundreds of lawsuits it faces over its alleged role in the opioid crisis. Allergan claims the allegations in the opioid litigation involve improper marketing and sale of sale of morphine drug Kadian in the years before it acquired the rights to it. Allergan, then known as Actavis Plc, acquired Kadian in December 2008 from a company that was later acquired by Pfizer.

  • Investopedia2 months ago

    Marijuana ETFs: The Pros and Cons

    In the United States, cannabis legalization has moved at an incremental pace, with individual states adopting different approaches to marijuana for either medical or recreational purposes, or both. While advocates continue to push for nationwide legalization, even the piecemeal road to legal cannabis that has already developed has generated a sizable new industry. For many investors, the idea of a regulated, legal marijuana industry suggests ample new opportunities for investment and growth.

  • Investopedia3 months ago

    3 Charts Suggest It's Time to Invest in Sin Stocks

    Rising volatility due to weakening in investor sentiment has some people concerned of a potential reversal across the financial markets. It is no secret that risk-averse investors have been spending the past several weeks in search of sectors and asset classes that will protect their capital in the event of a significant pullback. In the paragraphs below, we'll take a closer look at charts of vice-related assets with a specific focus on alcohol companies since they seem to be outperforming the broader group.

  • InvestorPlace3 months ago

    Here Are the Only Two Marijuana ETFs U.S. Investors Need Consider

    Last week, marijuana exchange-traded funds (ETFs) and stocks rallied after Canada legalized recreational marijuana. Not only did Canada legalize recreational marijuana, that country is home to more marijuana ETFs than are listed here in the U.S. For the time being, the universe of U.S. marijuana ETFs is sparsely populated.

  • Canada Legalizes Marijuana: Two ETFs to Tap the Boom
    Zacks4 months ago

    Canada Legalizes Marijuana: Two ETFs to Tap the Boom

    The outlook for the marijuana industry has brightened after Canada legalized nationwide recreational use of cannabis. Here are two ETFs to tap the boom.

  • ETF Trends4 months ago

    Marijuana ETFs Grow on Canadian Parliament’s Ruling

    Pot stocks and marijuana ETFs grew Wednesday after Canada's parliament legalized recreational marijuana. Canada's Senate approved a bill from Prime Minister Justin Trudeau's government to legalize cannabis, reports Jen Skerritt for Bloomberg. The move “paves the way for legal sales to begin,” Bloomberg Intelligence analyst Kenneth Shea said Wednesday in a report.

  • Marijuana Stocks: This Unique Weed Merger Offers Tech, Eyes U.S. Listing
    Investor's Business Daily5 months ago

    Marijuana Stocks: This Unique Weed Merger Offers Tech, Eyes U.S. Listing

    Cannabis tech and infrastructure outfit TILT Holdings is "absolutely" considering listing on a U.S. exchange after the company merges, its CEO told IBD in an interview.

  • Investopedia5 months ago

    Marijuana ETFs Experience Setbacks

    The legal marijuana industry is a nascent space that many investors believe is full of tremendous potential. It seems that almost every day there is news about a shift in legal status, a change in regulation and oversight, or some other adjustment. At the same time, though, marijuana exchange-traded funds (ETFs) have been in a holding pattern of sorts, according to etf.com.

  • 3 Marijuana ETFs for Everyday Investors to Play the Cannabis Movement
    InvestorPlace5 months ago

    3 Marijuana ETFs for Everyday Investors to Play the Cannabis Movement

    Four years ago, the marijuana legalization movement was firmly underway. Cannabis, both medical and recreational, was on more state ballots than ever before. And though many of those referendums were ultimately rejected, some got the green light. And simply appearing on a ballot at all was a victory for the cannabis industry.

  • Futures point slightly lower, Trump bashes OPEC over oil prices
    Yahoo Finance6 months ago

    Futures point slightly lower, Trump bashes OPEC over oil prices

    Yahoo Finance's LIVE market coverage and analysis of what you need to watch in the stock market begins each day at 9:25 a.m. ET.

  • Marijuana and Blockchain: 2018's Hottest New ETFs
    Zacks8 months ago

    Marijuana and Blockchain: 2018's Hottest New ETFs

    You asked for them, and now they've arrived. ETFs for two of the top investing trends.

  • TheStreet.com8 months ago

    Allergan CEO: We Are Staying in Ireland

    On an earnings call, Allergan's top executive rejected the possibility of moving back to the U.S. on the heels of the new tax law.

  • Reuters8 months ago

    Allergan to pay Israel's Teva Pharm $700 million to settle dispute

    Allergan (AGN.N) will make a one-time payment of $700 million to Teva Pharmaceutical Industries (TEVA.TA) to settle a dispute over working capital, Israel-based Teva said on Thursday. Teva will use the payment, which is expected during the first quarter of 2018, to repay part of its debt. Teva (TEVA.N) and Allergan agreed to jointly dismiss the working capital dispute arbitration.